Targeting cancer cell-specific RNA interference by siRNA delivery using a complex carrier of affibody-displaying bio-nanocapsules and liposomes

Journal of Nanobiotechnology

Volumn 11, Issue 1, 2013, Pages

  Nishimura, Yuya ^a   Mieda, Hiroaki ^a   Ishii, Jun ^a   Ogino, Chiaki ^a   Fujiwara, Toshinobu ^b   Kondo, Akihiko ^a  

^a KOBE UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Affibody; Bio nanocapsule; Hepatitis B virus; HER2; RNA interference; SiRNA

Indexed keywords

AFFIBODY; BIO NANOCAPSULES; HEPATITIS B VIRUS; HER2; RNA INTERFERENCE; SIRNA;

CELL MEMBRANES; CYTOLOGY; GENETIC ENGINEERING; LIPOSOMES; NANOCAPSULES; VIRUSES;

RNA;

LIPOSOME; NANOCAPSULE; SMALL INTERFERING RNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN;

ARTICLE; CANCER CELL; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENCAPSULATION; HUMAN; HUMAN CELL; RNA INTERFERENCE; CELL SURVIVAL; CHEMISTRY; FLUORESCENCE; GENE TRANSFER; LIGHT; METABOLISM; NEOPLASM; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; RADIATION SCATTERING; REPRODUCIBILITY; STATIC ELECTRICITY; TUMOR CELL LINE;

HEPATITIS B VIRUS;

CELL LINE, TUMOR; CELL SURVIVAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENCE; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; LIGHT; LIPOSOMES; NANOCAPSULES; NEOPLASMS; PARTICLE SIZE; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SCATTERING, RADIATION; STATIC ELECTRICITY;

EID: 84879204063     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-11-19     Document Type: Article

References (23)

1. Cardoso A, Trabulo S, Moreira JN, Düzgüneş N, de Lima MC. Targeted lipoplexes for siRNA delivery. Methods Enzymol 2009, 465:267-287.
2. Tseng YC, Mozumdar S, Huang L. Lipid-based systemic delivery of siRNA. Adv Drug Deliv Rev 2009, 61(9):721-731. 10.1016/j.addr.2009.03.003, 3172140, 19328215.
3. Lundberg P, El-Andaloussi S, Sütlü T, Johansson H, Langel U. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J 2007, 21(11):2664-2671. 10.1096/fj.06-6502com, 17463227.
4. Chang CI, Kim HA, Dua P, Kim S, Li CJ, Lee DK. Structural diversity repertoire of gene silencing small interfering RNAs. Nucleic Acid Ther 2011, 21(3):125-131. 3198623, 21749289.
5. Miele E, Spinelli GP, Miele E, Di Fabrizio E, Ferretti E, Tomao S, Gulino A. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy. Int J Nanomed 2012, 7:3637-3657.
6. Spagnou S, Miller AD, Keller M. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 2004, 43(42):13348-13356. 10.1021/bi048950a, 15491141.
7. Wirth M, Fritsche P, Stojanovic N, Brandl M, Jaeckel S, Schmid RM, Saur D, Schneider G. A simple and cost-effective method to transfect small interfering RNAs into pancreatic cancer cell lines using polyethylenimine. Pancreas 2011, 40(1):144-150. 10.1097/MPA.0b013e3181f7e41c, 20938367.
8. Kuroda S, Otaka S, Miyazaki T, Nakao M, Fujisawa Y. Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. J Biol Chem 1992, 267:1953-1961.
9. Yamada T, Iwasaki Y, Tada H, Iwabuki H, Chuah MK, VandenDriessche T, Fukuda H, Kondo A, Ueda M, Seno M, Tanizawa K, Kuroda S. Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat Biotechnol 2003, 21:885-890. 10.1038/nbt843, 12833071.
10. Kasuya T, Jung J, Kadoya H, Matsuzaki T, Tatematsu K, Okajima T, Miyoshi E, Tanizawa K, Kuroda S. In vivo delivery of bionanocapsules displaying phaseolus vulgarisAgglutinin-L4 isolectin to malignant tumors overexpressing N-acetylglucosaminyltransferase V. Human Gene Therapy 2008, 19(9):887-895. 10.1089/hum.2008.037, 18717644.
11. Orlova A, Magnusson M, Eriksson TL, Nilsson M, Larsson B, Hoiden-Guthenberg I, Widstrom C, Carlsson J, Tolmachev V, Stahl S, Nilsson FY. Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res 2006, 66:4339-4348. 10.1158/0008-5472.CAN-05-3521, 16618759.
12. Shishido T, Mieda H, Hwang SY, Nishimura Y, Tanaka T, Ogino C, Fukuda H, Kondo A. Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells. Bioorg Med Chem Lett 2010, 20:5726-5731. 10.1016/j.bmcl.2010.08.011, 20801029.
13. Kurata N, Shishido T, Muraoka M, Tanaka T, Ogino C, Fukuda H, Kondo A. Specific protein delivery to target cells by antibody-displaying bionanocapsules. J Biochem 2008, 144(6):701-707. 10.1093/jb/mvn131, 18838435.
14. Jung J, Matsuzaki T, Tatematsu K, Okajima T, Tanizawa K, Kuroda S. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials. J Control Release 2008, 126:255-264. 10.1016/j.jconrel.2007.12.002, 18207275.
15. Kasuya T, Jung J, Kinoshita R, Goh Y, Matsuzaki T, Iijima M, Yoshimoto N, Tanizawa K, Kuroda S. Bio-nanocapsule-liposome conjugates for in vivo pinpoint drug and gene delivery. Methods Enzymol 2009, 464:147-166.
16. Nishimura Y, Ishii J, Okazaki F, Ogino C, Kondo A. Complex carriers of affibody-displaying bio-nanocapsules and composition-varied liposomes for HER2-expressing breast cancer cell-specific protein delivery. J Drug Target 2012, 20(10):897-905. 10.3109/1061186X.2012.725404, 23020553.
17. Davison Z, Blacquiere GE, Westley BR, May FEB. Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implication for therapy. Neoplasia 2011, 13:504-515. 3114244, 21677874.
18. Jia LT, Zhang LH, Yu CJ, Zhao J, Xu YM, Gui JH, Jin M, Ji ZL, Wen WH, Wang CJ. Specific tumoricidal activity of a secreted proapototic protein consisting of HER2 antibody and constitutively active caspase-3. Cancer Res 2003, 63:3257-3262.
19. Kim SH, Mok H, Jeong JH, Kim SW, Park TG. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Bioconjug Chem 2006, 17(1):241-244. 10.1021/bc050289f, 16417275.
20. Naeye B, Raemdonck K, Remaut K, Sproat B, Demeester J, De Smedt SC. PEGylation of biodegradable dextran nanogels for siRNA delivery. Eur J Pharm Sci 2010, 40(4):342-351. 10.1016/j.ejps.2010.04.010, 20435139.
21. Lee SH, Bae KH, Kim SH, Lee KR, Park TG. Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers. Int J Pharm 2008, 364(1):94-101. 10.1016/j.ijpharm.2008.07.027, 18723087.
22. Metwally AA, Blagbrough IS, Mantell JM. Quantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterol. Mol Pharm 2012, 9(11):3384-3395. 10.1021/mp300435x, 3495574, 23057412.
23. Hatakeyama H, Akita H, Harashima H. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. Adv Drug Deliv Rev 2011, 63(3):152-160. 10.1016/j.addr.2010.09.001, 20840859.